Hemlibra 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26F9DY0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,169
Award facts
- Contract value 100% obligated
- $63,169.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $63,169.44 to AmerisourceBergen Drug Corp for the supply of HEMLIBRA 150 mg/ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle through December 2026.
HEMLIBRA is a specialty hemophilia treatment, reflecting the critical nature of AmerisourceBergen's pharmaceutical distribution role supporting military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive federal contract awards with the Defense Logistics Agency for a broad range of medical supplies and medications. The company's capability to supply specialized therapeutic products such as HEMLIBRA demonstrates its importance to the Defense Health Agency and other government healthcare systems requiring access to high-value biopharmaceutical treatments for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9DY0?
SPE2DR26F9DY0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9DY0 worth?
The government has obligated $63,169 on SPE2DR26F9DY0.
Is contract SPE2DR26F9DY0 an order under another contract?
Yes. SPE2DR26F9DY0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DY0 competed?
The extent of competition for SPE2DR26F9DY0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award